NEW

Johnson & Johnson to Acquire Shockwave Medical

Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, corresponding to an enterprise value of...

Medline Expands Catheter Portfolio

Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD)....

FDA Clears Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later...

Brainlab, Fujifilm Offer Advanced Neurosurgery Capabilities

FUJIFILM Healthcare Americas Corporation and Brainlab recently announced that Brainlab will be the exclusive U.S. distributor of ARIETTA Precision Ultrasound for neurosurgery applications to be utilized with Brainlab’s surgical navigation systems. ARIETTA Precision,...

Low-temperature plasma can sterilize medical facemasks

By Holly Ober

A low-temperature plasma. (Lorenzo Mangolini/UCR)

The shortage of N95 and surgical masks has complicated efforts to control the COVID-19 pandemic and jeopardized the lives of health care workers, who are forced to reuse masks many times.

Lorenzo Mangolini, an associate professor of mechanical engineering and materials science, and Joshua Morgan and Justin Chartron, assistant professors of bioengineering, have joined forces to investigate the use of low-temperature plasmas — partially ionized gases — to sterilize facemasks for safer reuse.

Surgical and N95 masks are made of fine polymer fibers, which act as a filter. They are too delicate for usual sterilization techniques such as the autoclave, which uses too high a temperature; and UV light, which does not penetrate deeply between the fibers. Low-temperature plasmas generate a broad range of bacteria- and virus-killing properties, while the temperature remains close to room temperature.

Untreated E. coli bacteria (left) and after a short treatment with low-temperature plasma (right). Longer treatment killed all the bacteria. (Troy Alva/UCR)

The faculty researchers, along with doctoral students Joseph Schwan, Troy Alva, and Brian Lupish; and postdoctoral scholar Giorgio Nava, contaminated surgical masks with E. coli, a bacterium commonly used to test sterilization, and subjected the masks to several minutes of the low-temperature plasma.

The masks were thoroughly sterilized, a promising result considering E. coli typically resist sterilization better than viruses.

The next step is to test the sterilization technique on masks that contain SARS-CoV-2, the virus that causes COVID-19.

The investigators envision developing a small, inexpensive, and potentially portable instrument that can be used by hospitals and clinics to routinely disinfect their masks.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X